이필휴 (연세대학교 의과대학)님 | 한빛사연구자 > 한빛사

Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease

DPP-4 inhibitor alleviates gut-brain axis pathology in Parkinson's disease

Gut, Oct 02 2025, gutjnl-2025-334988 | https://doi.org/10.1136/gutjnl-2025-334988

Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease

A selective ER-phagy exerts neuroprotective effects via modulation of α-synuclein clearance in parkinsonian models.

Proc. Natl. Acad. Sci. USA, Sep 12 2023, 120 (37) | https://doi.org/10.1073/pnas.2221929120

Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment

Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease

Neurology, December 13, 2022; 99 (24) | https://doi.org/10.1212/WNL.0000000000201269

Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum

Neurology, First published August 19, 2022 | https://doi.org/10.1212/WNL.0000000000200989

Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies

Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease

Neurology, First published February 21, 2022 | https://doi.org/10.1212/WNL.0000000000200152

Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Diabetic Patients With AD-Related Cognitive Impairment

저자논문